Catalent Securities Settlement: Eligibility, Claims, and Deadlines

If you owned Catalent, Inc. securities during the pandemic-era class period, you may be entitled to money from the $78 million Catalent securities class action settlement, and the claim deadline is May 26, 2026. The settlement covers investors who purchased Catalent common stock, bought exchange-traded call options, or sold exchange-traded put options between August 30, 2021, and May 7, 2023. A federal judge in New Jersey granted preliminary approval on December 29, 2025, and claims are being processed now.¹

Who Qualifies as a Class Member

The settlement class includes every person or entity that, during the class period of August 30, 2021 through May 7, 2023, did any of the following:

Purchased or otherwise acquired Catalent’s publicly traded common stock.
Purchased exchange-traded Catalent call options.
Sold exchange-traded Catalent put options.²

Transactions outside those dates or in instruments not listed above are not covered.

How to File a Claim

You can file in one of two ways. Online submissions go through the official settlement site at www.CatalentSecuritiesSettlement.com. Paper claim forms can be mailed to:

Catalent Securities Settlement
P.O. Box 2683
Portland, OR 97208-2683

A blank claim form is available for download on the settlement website or by calling the claims administrator at (877) 239-4873.²

Expect the form to ask for records of your Catalent trades during the class period, including purchase and sale dates, share or contract counts, and prices. Brokerage confirmations or account statements are the usual documentation.

Deadlines You Need to Meet

Three dates matter, and missing them forfeits your rights in different ways.

May 26, 2026 — deadline to submit a claim form. Miss this and you get no payment, though you remain bound by the settlement.²
May 20, 2026 — deadline to request exclusion from the class if you want to preserve the right to sue on your own.³
May 20, 2026 — deadline to file a written objection to the settlement, the plan of allocation, or the fee request.³

What Class Members Might Receive

Individual payments depend on how many valid claims come in, how many shares or contracts each claimant held, and when those trades occurred relative to the alleged corrective disclosures. There is no fixed per-share figure.

The $78 million fund will also be reduced before distribution. Co-lead counsel have asked the court to approve attorneys’ fees of up to 25% of the fund, which caps out at $19.5 million, plus litigation expense reimbursement of up to $2 million. Notice costs, claims administration, and taxes come out of the fund as well. What’s left, the Net Settlement Fund, is what actually gets divided among claimants under the court-approved plan of allocation.⁴

If You Do Nothing

Doing nothing has consequences. You will not receive any money, and you will still be legally bound by the release built into the settlement. That means you give up the right to sue Catalent or the individual defendants over the same claims covered by the case.³ Filing a claim by the May 26, 2026 deadline is the only way to be paid; opting out by May 20, 2026 is the only way to preserve independent legal rights.

What the Lawsuit Alleged

The case, City of Warwick Retirement System v. Catalent, Inc., was filed in the U.S. District Court for the District of New Jersey and later led by the Public Employees’ Retirement System of Mississippi and SEB Investment Management AB. It named Catalent along with three former executives: John Chiminski (CEO through July 2022, then Executive Chair), Alessandro Maselli (President and COO, later CEO), and Thomas Castellano (CFO during the class period).⁵

Plaintiffs claimed the defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 by misleading investors as COVID-19 vaccine demand fell off in mid-2021. According to the complaint, Catalent inflated revenue through premature recognition and channel stuffing, cut corners on quality control at manufacturing plants in Bloomington, Indiana; Brussels, Belgium; and Harmans, Maryland, and made public statements portraying strong non-COVID demand that did not match reality.⁶¹

Catalent later disclosed a $26 million revenue recognition error from its fiscal year ended June 30, 2022, tied to contract modification accounting at the Bloomington site, and acknowledged in an SEC filing that it did “not presently maintain effective disclosure controls and procedures” because of material weaknesses in internal controls over financial reporting.⁷ The defendants deny any liability or wrongdoing, and the settlement resolves the case without any admission.²

Approval Status and Catalent Today

Preliminary approval was granted on December 29, 2025. A settlement hearing had been scheduled for June 10, 2026, but the court canceled it and said it would rule on the pending approval motions based on the written submissions. Final approval is still pending.¹

Catalent is no longer publicly traded. In December 2024, Novo Holdings completed an all-cash acquisition of the company for $16.5 billion, paying shareholders $63.50 per share, and Catalent’s common stock was delisted from the New York Stock Exchange.⁸ That transaction is separate from this securities settlement. Owning Catalent shares at the time of the Novo buyout does not, on its own, qualify you for a payment here; eligibility turns on your trading activity during the August 30, 2021 to May 7, 2023 class period.

1
Labaton Keller Sucharow. City of Warwick Retirement System v. Catalent, Inc.
2
PR Newswire. Labaton Keller Sucharow and Kessler Topaz Announce Pendency and Proposed Settlement of Catalent Securities Class Action
3
Catalent Securities Settlement. Catalent Securities Settlement
4
Catalent Securities Settlement. Frequently Asked Questions
5
D&D Diary. Catalent Complaint
6
Kessler Topaz Meltzer & Check. Catalent, Inc.
7
SEC. Catalent, Inc. Form 10-Q
8
Pharmaceutical Technology. Novo Holdings Catalent Acquisition